JP2022514348A5 - - Google Patents

Info

Publication number
JP2022514348A5
JP2022514348A5 JP2021535547A JP2021535547A JP2022514348A5 JP 2022514348 A5 JP2022514348 A5 JP 2022514348A5 JP 2021535547 A JP2021535547 A JP 2021535547A JP 2021535547 A JP2021535547 A JP 2021535547A JP 2022514348 A5 JP2022514348 A5 JP 2022514348A5
Authority
JP
Japan
Prior art keywords
group
compound according
antibody
derived
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2021535547A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022514348A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/068178 external-priority patent/WO2020132655A1/en
Publication of JP2022514348A publication Critical patent/JP2022514348A/ja
Publication of JP2022514348A5 publication Critical patent/JP2022514348A5/ja
Priority to JP2024163811A priority Critical patent/JP2024178320A/ja
Ceased legal-status Critical Current

Links

JP2021535547A 2018-12-21 2019-12-20 チオール多重リンカーを有するadc Ceased JP2022514348A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024163811A JP2024178320A (ja) 2018-12-21 2024-09-20 チオール多重リンカーを有するadc

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862783582P 2018-12-21 2018-12-21
US201862783707P 2018-12-21 2018-12-21
US62/783,582 2018-12-21
US62/783,707 2018-12-21
PCT/US2019/068178 WO2020132655A1 (en) 2018-12-21 2019-12-20 Adcs with thiol multiplex linkers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024163811A Division JP2024178320A (ja) 2018-12-21 2024-09-20 チオール多重リンカーを有するadc

Publications (2)

Publication Number Publication Date
JP2022514348A JP2022514348A (ja) 2022-02-10
JP2022514348A5 true JP2022514348A5 (cg-RX-API-DMAC7.html) 2022-12-20

Family

ID=71101991

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021535547A Ceased JP2022514348A (ja) 2018-12-21 2019-12-20 チオール多重リンカーを有するadc
JP2024163811A Pending JP2024178320A (ja) 2018-12-21 2024-09-20 チオール多重リンカーを有するadc

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024163811A Pending JP2024178320A (ja) 2018-12-21 2024-09-20 チオール多重リンカーを有するadc

Country Status (12)

Country Link
US (1) US20220040320A1 (cg-RX-API-DMAC7.html)
EP (1) EP3897734A4 (cg-RX-API-DMAC7.html)
JP (2) JP2022514348A (cg-RX-API-DMAC7.html)
KR (1) KR20210141918A (cg-RX-API-DMAC7.html)
CN (1) CN113543812A (cg-RX-API-DMAC7.html)
AU (1) AU2019403552A1 (cg-RX-API-DMAC7.html)
CA (1) CA3122316A1 (cg-RX-API-DMAC7.html)
IL (1) IL284147A (cg-RX-API-DMAC7.html)
MX (1) MX2021007548A (cg-RX-API-DMAC7.html)
SG (1) SG11202106122QA (cg-RX-API-DMAC7.html)
TW (1) TW202039008A (cg-RX-API-DMAC7.html)
WO (1) WO2020132655A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021251875A1 (en) * 2020-04-10 2022-11-03 Seagen Inc. Charge variant linkers
IL317037A (en) * 2022-05-18 2025-01-01 Systimmune Inc Ligand-drug conjugate and its uses
EP4651905A1 (en) * 2023-01-17 2025-11-26 Eli Lilly and Company Novel linkers for sustained delivery of therapeutics
LT4601703T (lt) 2023-04-18 2026-06-25 Astrazeneca Ab Konjugatai, apimantys atskeliamuosius jungtukus

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0871490B1 (en) * 1995-12-22 2003-03-19 Bristol-Myers Squibb Company Branched hydrazone linkers
EP0941120A4 (en) * 1996-11-05 2004-08-18 Bristol Myers Squibb Co BRANCHED PEPTIDLINKERS
DE10048417A1 (de) * 2000-09-29 2002-04-11 Roche Diagnostics Gmbh Verbindungen mit verzweigtem Linker
US6821529B2 (en) * 2001-09-05 2004-11-23 Deanna Jean Nelson Oligo(ethylene glycoll)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers
WO2007132998A1 (en) * 2006-05-12 2007-11-22 Korea Research Institute Of Bioscience And Biotechnology Linker molecules for substrate surface treatment and specific protein immobilization, and method for preparing the same
WO2012024613A1 (en) * 2010-08-19 2012-02-23 Wintrance Corporation Synergistic biomolecule-polymer conjugates
WO2008147481A1 (en) * 2007-02-09 2008-12-04 Northeastern University Precision-guided nanoparticle systems for drug delivery
EP3842074A1 (en) * 2010-09-29 2021-06-30 Philogen S.p.A. Protein-drug conjugates
CN104822656B (zh) * 2012-05-15 2018-05-01 西雅图基因公司 自稳定接头偶联物
CN104640572B (zh) * 2012-05-15 2018-04-27 索伦托医疗有限公司 药物偶联物,偶联方法,及其用途
PL2872157T3 (pl) * 2012-07-12 2020-07-13 Hangzhou Dac Biotech Co., Ltd Koniugaty wiążących komórkę cząsteczek ze środkami cytotoksycznymi
JP2016531915A (ja) * 2013-08-28 2016-10-13 ステムセントリックス, インコーポレイテッド 部位特異的抗体コンジュゲーション方法および組成物
TW201511774A (zh) * 2013-09-18 2015-04-01 Iner Aec Executive Yuan 放射性標誌之主動標靶性醫藥組合物及其用途
PT3057585T (pt) * 2013-10-15 2020-10-21 Seagen Inc Fármaco-ligadores peguilados para farmacocinética melhorada de conjugados de fármaco-ligando
WO2016025752A1 (en) * 2014-08-14 2016-02-18 Prolynx Llc Reagents for thiol conjugation and conjugates formed therefrom
US11135307B2 (en) * 2016-11-23 2021-10-05 Mersana Therapeutics, Inc. Peptide-containing linkers for antibody-drug conjugates
AU2021251875A1 (en) * 2020-04-10 2022-11-03 Seagen Inc. Charge variant linkers

Similar Documents

Publication Publication Date Title
CN112261954B (zh) 具有针对抗体的亲和性物质和生物正交性官能团的化合物或其盐
JP2023534437A5 (cg-RX-API-DMAC7.html)
JP2020519643A5 (cg-RX-API-DMAC7.html)
JP2024167313A5 (cg-RX-API-DMAC7.html)
JP2023081303A5 (cg-RX-API-DMAC7.html)
JP2024149655A5 (cg-RX-API-DMAC7.html)
JP2015526434A5 (cg-RX-API-DMAC7.html)
JP2014224121A5 (cg-RX-API-DMAC7.html)
JPWO2020031936A5 (cg-RX-API-DMAC7.html)
JP2012500006A5 (cg-RX-API-DMAC7.html)
PE20060817A1 (es) Anticuerpos anti-5t4 humanizados y conjugados anticuerpo anti-5t4/calicheamicina
JP2020506685A5 (cg-RX-API-DMAC7.html)
JP2018509394A5 (cg-RX-API-DMAC7.html)
JP2023512501A5 (cg-RX-API-DMAC7.html)
JP2004248677A5 (cg-RX-API-DMAC7.html)
JP2020513019A5 (cg-RX-API-DMAC7.html)
SA516371381B1 (ar) مواد اقتران عقار جسم مضاد (adcs) مع بروتين مغزل كينسين (ksp)
JPH07505283A (ja) Dnaトランスポーター系および使用方法
JP2026053355A5 (cg-RX-API-DMAC7.html)
JP2023542295A5 (cg-RX-API-DMAC7.html)
JP2021517471A5 (cg-RX-API-DMAC7.html)
JPWO2019230645A5 (cg-RX-API-DMAC7.html)
JP2020526497A5 (cg-RX-API-DMAC7.html)
JP2024535925A5 (cg-RX-API-DMAC7.html)
JP2024508709A5 (cg-RX-API-DMAC7.html)